STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

ARTL ARTELO BIOSCIENCES INCORPORATED StockScouter® Report

4

StockScouter® Score

ARTELO BIOSCIENCES INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Shares are under accumulation by financial institutions. Marginally positive for a small company like ARTL

 

Concerns

  • The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
  • Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 60% done.
Progress: 20% done.
Low
High

Core Model Grades

F
C
N/A
D

Previous Ratings

4
6
5